SEC Filings

Filing date	Form	Description	View
05/18/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-007541.pdf 0001179110-17-007541.rtf
05/18/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-007539.pdf 0001179110-17-007539.rtf
05/18/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-007537.pdf 0001179110-17-007537.rtf
05/18/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-007538.pdf 0001179110-17-007538.rtf
05/18/17	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-17-033777.pdf 0001104659-17-033777.rtf 0001104659-17-033777.xls
05/10/17	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-17-031266.pdf 0001104659-17-031266.rtf 0001104659-17-031266.xls
05/10/17	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001104659-17-031264.pdf 0001104659-17-031264.rtf 0001104659-17-031264.xls EX-101.INS - XBRL INSTANCE DOCUMENT
05/09/17	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-17-025639.pdf 0001144204-17-025639.rtf 0001144204-17-025639.xls
04/11/17	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001047469-17-002506.pdf 0001047469-17-002506.rtf 0001047469-17-002506.xls
03/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-004273.pdf 0001179110-17-004273.rtf 0001179110-17-004273.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.